Atrium Innovations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
22
About the Report
About the Report
Summary
Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets its products under brands such as Garden of Life, Klean Athlete, Minami and Orthica, among others. It has partnerships with academic institutes such as Institute of Nutrition and Functional Foods at Laval University; Cleveland Clinic Center for Functional Medicine and other commercial partners. The company also supports research projects at academic centers across the world. The company has manufacturing facilities in the US, Canada, Europe and Argentina. Atrium is headquartered in Quebec, Canada.
Atrium Innovations Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Permira Funds Completes Acquisition Of Atrium Innovations For USD 1.04 Billion 10
Partnerships 13
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Licensing Agreements 14
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Acquisition 15
Nestle to Acquire Atrium Innovations for USD2.3 Billion 15
Atrium Innovations Acquires 70% Stake In Mucos Pharma 17
Atrium Innovations Inc-Key Competitors 18
Atrium Innovations Inc-Key Employees 19
Atrium Innovations Inc-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Figure
List of Figures
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Permira Funds Completes Acquisition Of Atrium Innovations For USD 1.04 Billion 10
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Nestle to Acquire Atrium Innovations for USD2.3 Billion 15
Atrium Innovations Acquires 70% Stake In Mucos Pharma 17
Atrium Innovations Inc, Key Competitors 18
Atrium Innovations Inc, Key Employees 19
Atrium Innovations Inc, Subsidiaries 20
Atrium Innovations Inc, Joint Venture 21
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.